vs

Side-by-side financial comparison of Dexcom (DXCM) and RXO, Inc. (RXO). Click either name above to swap in a different company.

RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Dexcom). Dexcom runs the higher net margin — 21.2% vs -3.1%, a 24.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -11.9%). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 12.0%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

DXCM vs RXO — Head-to-Head

Bigger by revenue
RXO
RXO
1.2× larger
RXO
$1.5B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+33.5% gap
DXCM
21.6%
-11.9%
RXO
Higher net margin
DXCM
DXCM
24.4% more per $
DXCM
21.2%
-3.1%
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
12.0%
DXCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DXCM
DXCM
RXO
RXO
Revenue
$1.3B
$1.5B
Net Profit
$267.3M
$-46.0M
Gross Margin
62.9%
Operating Margin
25.6%
-2.9%
Net Margin
21.2%
-3.1%
Revenue YoY
21.6%
-11.9%
Net Profit YoY
153.6%
-84.0%
EPS (diluted)
$0.67
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
RXO
RXO
Q1 26
$1.3B
Q4 25
$1.3B
$1.5B
Q3 25
$1.2B
$1.4B
Q2 25
$1.2B
$1.4B
Q1 25
$1.0B
$1.4B
Q4 24
$1.1B
$1.7B
Q3 24
$994.2M
$1.0B
Q2 24
$1.0B
$930.0M
Net Profit
DXCM
DXCM
RXO
RXO
Q1 26
$267.3M
Q4 25
$267.3M
$-46.0M
Q3 25
$283.8M
$-14.0M
Q2 25
$179.8M
$-9.0M
Q1 25
$105.4M
$-31.0M
Q4 24
$151.7M
$-25.0M
Q3 24
$134.6M
$-243.0M
Q2 24
$143.5M
$-7.0M
Gross Margin
DXCM
DXCM
RXO
RXO
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
RXO
RXO
Q1 26
25.6%
Q4 25
25.6%
-2.9%
Q3 25
20.1%
-0.5%
Q2 25
18.4%
Q1 25
12.9%
-2.1%
Q4 24
17.0%
-1.4%
Q3 24
15.3%
-1.9%
Q2 24
15.7%
Net Margin
DXCM
DXCM
RXO
RXO
Q1 26
21.2%
Q4 25
21.2%
-3.1%
Q3 25
23.5%
-1.0%
Q2 25
15.5%
-0.6%
Q1 25
10.2%
-2.2%
Q4 24
13.6%
-1.5%
Q3 24
13.5%
-23.4%
Q2 24
14.3%
-0.8%
EPS (diluted)
DXCM
DXCM
RXO
RXO
Q1 26
$0.67
Q4 25
$0.67
$-0.28
Q3 25
$0.70
$-0.08
Q2 25
$0.45
$-0.05
Q1 25
$0.27
$-0.18
Q4 24
$0.37
$-0.17
Q3 24
$0.34
$-1.81
Q2 24
$0.35
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$917.7M
$17.0M
Total DebtLower is stronger
$387.0M
Stockholders' EquityBook value
$2.7B
$1.5B
Total Assets
$6.3B
$3.3B
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
RXO
RXO
Q1 26
$917.7M
Q4 25
$917.7M
$17.0M
Q3 25
$1.8B
$25.0M
Q2 25
$1.2B
$18.0M
Q1 25
$904.9M
$16.0M
Q4 24
$606.1M
$35.0M
Q3 24
$621.2M
$55.0M
Q2 24
$939.2M
$7.0M
Total Debt
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
$387.0M
Q3 25
$387.0M
Q2 25
$387.0M
Q1 25
$387.0M
Q4 24
$351.0M
Q3 24
$352.0M
Q2 24
$370.0M
Stockholders' Equity
DXCM
DXCM
RXO
RXO
Q1 26
$2.7B
Q4 25
$2.7B
$1.5B
Q3 25
$2.7B
$1.6B
Q2 25
$2.6B
$1.6B
Q1 25
$2.3B
$1.6B
Q4 24
$2.1B
$1.6B
Q3 24
$2.0B
$1.7B
Q2 24
$2.4B
$579.0M
Total Assets
DXCM
DXCM
RXO
RXO
Q1 26
$6.3B
Q4 25
$6.3B
$3.3B
Q3 25
$7.5B
$3.2B
Q2 25
$7.3B
$3.2B
Q1 25
$6.8B
$3.3B
Q4 24
$6.5B
$3.4B
Q3 24
$6.4B
$3.4B
Q2 24
$6.8B
$1.8B
Debt / Equity
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
0.25×
Q3 25
0.24×
Q2 25
0.24×
Q1 25
0.24×
Q4 24
0.22×
Q3 24
0.21×
Q2 24
0.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
RXO
RXO
Operating Cash FlowLast quarter
$7.0M
Free Cash FlowOCF − Capex
$-9.0M
FCF MarginFCF / Revenue
-0.6%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
$294.0M
$7.0M
Q3 25
$659.9M
$23.0M
Q2 25
$303.0M
$23.0M
Q1 25
$183.8M
$-2.0M
Q4 24
$301.4M
$-7.0M
Q3 24
$199.5M
$-7.0M
Q2 24
$279.4M
$-5.0M
Free Cash Flow
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
$192.1M
$-9.0M
Q3 25
$579.4M
$9.0M
Q2 25
$208.9M
$9.0M
Q1 25
$96.8M
$-17.0M
Q4 24
$176.8M
$-19.0M
Q3 24
$88.3M
$-18.0M
Q2 24
$213.3M
$-16.0M
FCF Margin
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
15.3%
-0.6%
Q3 25
47.9%
0.6%
Q2 25
18.1%
0.6%
Q1 25
9.3%
-1.2%
Q4 24
15.9%
-1.1%
Q3 24
8.9%
-1.7%
Q2 24
21.2%
-1.7%
Capex Intensity
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
8.1%
1.1%
Q3 25
6.7%
1.0%
Q2 25
8.1%
1.0%
Q1 25
8.4%
1.0%
Q4 24
11.2%
0.7%
Q3 24
11.2%
1.1%
Q2 24
6.6%
1.2%
Cash Conversion
DXCM
DXCM
RXO
RXO
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons